"
Team:SupBiotech-Paris/Acknowledgement
From 2009.igem.org
Project
Introduction Current therapies Gene therapies DVS Concept Tissue Vector Cell Vector Therapeutic plasmid Conclusion Implementation Tissue targeting Antitumor action Treatment modeling Conclusion
Ressources
BioBricks Material & Method Bibliography
Ethics & Safety
Contents |
UMR CNRS 8121 from the Gustave Roussy Institute
- Lluis M. Mir
- Karim Benihoud
INSERM U872
- Srinivas Kaveri
AnyGenes
- Benyoussef Naimi
Our Sponsors
- Embassy of France in Washington [Link]
- Eurogentec [Link]
- Takara [Link]
- Clonetech [Link]
- Promega [Link]
- Sigma-Aldrich [Link]
- Qiagen [Link]
- Fisher-Scientific [Link]
